Fidelity Select Pharmaceuticals Port (FPHAX)
* As of 30-Nov-14
Quotes delayed, except where indicated otherwise. Currency in USD.
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||0.81%|
Performance & Risk
|5y Avg Return:||22.61%|
|Rank in Category (ytd):||57|
|% Rank in Category (ytd):||45.24%|
|Morningstar Risk Rating:||3|
The investment seeks capital appreciation.
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified. View More